Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
Clinical trial NCT02583191 · TERMINATED
Trial details
- NCT number
- NCT02583191
- Sponsor
- AIO-Studien-gGmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-23
- Primary completion
- 2019-06-11
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.